Literature DB >> 15950124

The relationship between inhibition of bacterial adhesion to a solid surface by sub-MICs of antibiotics and subsequent development of a biofilm.

Nuno Cerca1, Silvia Martins, Gerald B Pier, Rosário Oliveira, Joana Azeredo.   

Abstract

Many studies have demonstrated that subminimal inhibitory concentrations (sub-MICs) of antibiotics can inhibit initial microbial adherence to medical device surfaces. It has been suggested that, by inhibiting initial adhesion, biofilm formation might be prevented. However, since initial adherence and subsequent biofilm formation may be two distinct phenomena, conclusions regarding the effects of sub-MIC antibiotics on initial adhesion cannot be extrapolated to biofilm formation. In this study, we evaluated the adherence of several clinical isolates of coagulase-negative staphylococci (CoNS) to acrylic and the effect of sub-MICs of vancomycin, cefazolin, dicloxacillin and combinations of these antibiotics on adherence and biofilm formation. Most of the antibiotics used resulted in effective reduction of bacterial adherence to acrylic, in some cases reaching over 70% inhibition of adherence. When strains with a high biofilm-forming capacity were grown in sub-MICs of those antibiotics, there existed combinations of the drugs that significantly inhibited biofilm formation. However, most of the antibiotic combinations that inhibited adherence did not have a profound effect on biofilm formation. When comparing the results of the effect of sub-MIC amounts of antibiotics in inhibiting adherence with their effect on the inhibition of biofilm formation, significant differences were found, mainly when using combinations of antibiotics. In general, the effect on the inhibition of adherence was greater than the effect on inhibiting biofilm formation. These results demonstrate that assays evaluating the inhibition of initial adherence to medical surfaces cannot fully predict the effect on inhibition of biofilm formation.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15950124      PMCID: PMC1351067          DOI: 10.1016/j.resmic.2005.02.004

Source DB:  PubMed          Journal:  Res Microbiol        ISSN: 0923-2508            Impact factor:   3.992


  27 in total

1.  Effect of subinhibitory concentrations of cefamandole and cefuroxime on adherence of Staphylococcus aureus and Staphylococcus epidermidis to polystyrene culture plates.

Authors:  H Carsenti-Etesse; J Durant; E Bernard; V Mondain; J Entenza; P Dellamonica
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1992-08       Impact factor: 3.267

2.  Vancomycin versus cefazolin prophylaxis for cardiac surgery in the setting of a high prevalence of methicillin-resistant staphylococcal infections.

Authors:  R Finkelstein; G Rabino; T Mashiah; Y Bar-El; Z Adler; V Kertzman; O Cohen; S Milo
Journal:  J Thorac Cardiovasc Surg       Date:  2002-02       Impact factor: 5.209

3.  Comparative evaluation of coagulase-negative staphylococci (CoNS) adherence to acrylic by a static method and a parallel-plate flow dynamic method.

Authors:  Nuno Cerca; Gerald B Pier; Rosário Oliveira; Joana Azeredo
Journal:  Res Microbiol       Date:  2004-11       Impact factor: 3.992

4.  The inhibition of bacterial adhesion to a tobramycin-impregnated polymethylmethacrylate substratum.

Authors:  M Oga; T Arizono; Y Sugioka; P T Naylor; Q N Myrvik; A G Gristina
Journal:  J Long Term Eff Med Implants       Date:  1992

5.  Cefuroxime vs a dicloxacillin/chloramphenicol combination for the treatment of parapneumonic pleural effusion and empyema in children.

Authors:  G C Palacios; S N Gonzalez; F L Perez; S F Cuevas; S F Solorzano
Journal:  Pulm Pharmacol Ther       Date:  2002       Impact factor: 3.410

6.  Furanones as potential anti-bacterial coatings on biomaterials.

Authors:  J K Baveja; M D P Willcox; E B H Hume; N Kumar; R Odell; L A Poole-Warren
Journal:  Biomaterials       Date:  2004-09       Impact factor: 12.479

7.  In-vitro efficacy of a central venous catheter complexed with iodine to prevent bacterial colonization.

Authors:  B Jansen; K G Kristinsson; S Jansen; G Peters; G Pulverer
Journal:  J Antimicrob Chemother       Date:  1992-08       Impact factor: 5.790

8.  Biofilm testing of Staphylococcus epidermidis clinical isolates: low performance of vancomycin in relation to other antibiotics.

Authors:  Marta Monzón; Concepción Oteiza; José Leiva; Marta Lamata; Beatriz Amorena
Journal:  Diagn Microbiol Infect Dis       Date:  2002-12       Impact factor: 2.803

9.  Effects on adhesiveness and hydrophobicity of sub-inhibitory concentrations of netilmicin.

Authors:  Pio Maria Furneri; Adriana Garozzo; Maria Pia Musumarra; Anna Claudia Scuderi; Andrea Russo; Giovanni Bonfiglio
Journal:  Int J Antimicrob Agents       Date:  2003-08       Impact factor: 5.283

10.  Effects of linezolid on staphylococcal adherence versus time of treatment.

Authors:  Paul J Pagano; Lewis V Buchanan; Charlene F Dailey; Joseph V Haas; Richard A Van Enk; John K Gibson
Journal:  Int J Antimicrob Agents       Date:  2004-03       Impact factor: 5.283

View more
  14 in total

1.  Comparative assessment of antibiotic susceptibility of coagulase-negative staphylococci in biofilm versus planktonic culture as assessed by bacterial enumeration or rapid XTT colorimetry.

Authors:  Nuno Cerca; Silvia Martins; Filipe Cerca; Kimberly K Jefferson; Gerald B Pier; Rosário Oliveira; Joana Azeredo
Journal:  J Antimicrob Chemother       Date:  2005-06-24       Impact factor: 5.790

2.  Effects of growth in the presence of subinhibitory concentrations of dicloxacillin on Staphylococcus epidermidis and Staphylococcus haemolyticus biofilms.

Authors:  Nuno Cerca; Silvia Martins; Sanna Sillankorva; Kimberly K Jefferson; Gerald B Pier; Rosario Oliveira; Joana Azeredo
Journal:  Appl Environ Microbiol       Date:  2005-12       Impact factor: 4.792

3.  Extracellular DNA-dependent biofilm formation by Staphylococcus epidermidis RP62A in response to subminimal inhibitory concentrations of antibiotics.

Authors:  Jeffrey B Kaplan; Saïd Jabbouri; Irina Sadovskaya
Journal:  Res Microbiol       Date:  2011-03-12       Impact factor: 3.992

4.  In vitro effects of antimicrobial agents on planktonic and biofilm forms of Staphylococcus lugdunensis clinical isolates.

Authors:  Kristi L Frank; Emily J Reichert; Kerryl E Piper; Robin Patel
Journal:  Antimicrob Agents Chemother       Date:  2006-12-11       Impact factor: 5.191

5.  Effects of azithromycin in combination with vancomycin, daptomycin, fosfomycin, tigecycline, and ceftriaxone on Staphylococcus epidermidis biofilms.

Authors:  Elisabeth Presterl; Stefan Hajdu; Andrea M Lassnigg; Alexander M Hirschl; Johannes Holinka; Wolfgang Graninger
Journal:  Antimicrob Agents Chemother       Date:  2009-05-18       Impact factor: 5.191

6.  The role of polysaccharide intercellular adhesin (PIA) in Staphylococcus epidermidis adhesion to host tissues and subsequent antibiotic tolerance.

Authors:  A R Costa; M Henriques; R Oliveira; J Azeredo
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2009-01-08       Impact factor: 3.267

7.  Antimicrobial and Antibiofilm Activity of Chitosan on the Oral Pathogen Candida albicans.

Authors:  Eduardo Costa; Sara Silva; Freni Tavaria; Manuela Pintado
Journal:  Pathogens       Date:  2014-12-11

8.  Bacteriophage ZCKP1: A Potential Treatment for Klebsiella pneumoniae Isolated From Diabetic Foot Patients.

Authors:  Omar A Taha; Phillippa L Connerton; Ian F Connerton; Ayman El-Shibiny
Journal:  Front Microbiol       Date:  2018-09-11       Impact factor: 5.640

Review 9.  Infection of orthopedic implants with emphasis on bacterial adhesion process and techniques used in studying bacterial-material interactions.

Authors:  Marta Ribeiro; Fernando J Monteiro; Maria P Ferraz
Journal:  Biomatter       Date:  2012 Oct-Dec

10.  Chemical composition, antimicrobial and antibiofilm activity of the essential oil and methanol extract of the Mediterranean cypress (Cupressus sempervirens L.).

Authors:  Samy A Selim; Mohammed E Adam; Sherif M Hassan; Abdulrhman R Albalawi
Journal:  BMC Complement Altern Med       Date:  2014-06-02       Impact factor: 3.659

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.